AAAAAA

   
Results: 1-20 |
Results: 20

Authors: ANDERSON SC JOHNSON DE HARRIS MP ENGLER H HANCOCK W HUANG WM WILLS KN GREGORY RJ SUTJIPTO S WEN SF LOFGREN S SHEPARD HM MANEVAL DC
Citation: Sc. Anderson et al., P53 GENE-THERAPY IN A RAT MODEL OF HEPATOCELLULAR-CARCINOMA - INTRAARTERIAL DELIVERY OF A RECOMBINANT ADENOVIRUS, Clinical cancer research, 4(7), 1998, pp. 1649-1659

Authors: LOPEZ F HANCOCK W
Citation: F. Lopez et W. Hancock, NAUSEA AND MALAISE DURING TREATMENT OF COCCIDIOIDOMYCOSIS, Hospital practice, 32(5), 1997, pp. 21-22

Authors: JOHNSON D MACHEMER T HANCOCK W WEN SF MANEVAL DC
Citation: D. Johnson et al., CHARACTERIZATION OF AN IMMUNODEFICIENT MOUSE MODEL OF HUMAN SMALL-CELL LUNG-CANCER (SCLC) FOR TUMOR-SUPPRESSOR GENE-THERAPY, Cancer gene therapy, 4(6), 1997, pp. 33-33

Authors: HARRIS MP SUTJIPTO S WILLS KN HANCOCK W CORNELL D JOHNSON DE GREGORY RJ SHEPARD HM MANEVAL DC
Citation: Mp. Harris et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER INHIBITS GROWTH OF HUMAN TUMOR-CELLS EXPRESSING MUTANT P53 PROTEIN, Cancer gene therapy, 3(2), 1996, pp. 121-130

Authors: BATTERSBY J CLARK R HANCOCK W PUCHULUCAMPANELLA E HAGGARTY N POLL D HARDING D
Citation: J. Battersby et al., SUSTAINED-RELEASE OF RECOMBINANT HUMAN GROWTH-HORMONE FROM DEXTRAN VIA HYDROLYSIS OF AN IMINE BOND, Journal of controlled release, 42(2), 1996, pp. 143-156

Authors: HANCOCK W WILLIS B
Citation: W. Hancock et B. Willis, THE FUTURE OF ANALYTICAL-CHEMISTRY IN THE CHARACTERIZATION OF BIOPHARMACEUTICALS, American laboratory, 28(9), 1996, pp. 31

Authors: KOCK H HARRIS MP ANDERSON SC MACHEMER T HANCOCK W SUTJIPTO S WILLS KN GREGORY RJ SHEPARD HM WESTPHAL M MANEVAL DC
Citation: H. Kock et al., ADENOVIRUS-MEDIATED P53 GENE-TRANSFER SUPPRESSES GROWTH OF HUMAN GLIOBLASTOMA CELLS IN-VITRO AND IN-VIVO, International journal of cancer, 67(6), 1996, pp. 808-815

Authors: HANCOCK W
Citation: W. Hancock, DEPRESSION, NOT ELEVATION - REPLY, Hospital practice, 30(7), 1995, pp. 14-14

Authors: TURKA LA AKALIN E HANCOCK W CARPENTER CB SAYEGH MH
Citation: La. Turka et al., CTLA4IG ESTABLISHES TRANSPLANTATION TOLERANCE THROUGH SPECIFIC INDUCTION OF TH2 CYTOKINES, Journal of cellular biochemistry, 1995, pp. 179-179

Authors: STEINOAKLEY A JABLONSKI P MAGUIRE J BAXTER K HANCOCK W THOMSON N
Citation: A. Steinoakley et al., UP-REGULATED CYTOKINE EXPRESSION IN CHRONIC RENAL-ALLOGRAFT REJECTION, Transplantation proceedings, 27(6), 1995, pp. 3581-3581

Authors: SALOM R MAGUIRE J ESMORE D HANCOCK W
Citation: R. Salom et al., ENDOTHELIAL-CELL ACTIVATION AND CYTOKINE EXPRESSION DURING ACUTE HUMAN CARDIAC ALLOGRAFT-REJECTION, Transplantation proceedings, 27(3), 1995, pp. 2164-2165

Authors: KARNOVSKY MJ RUSSELL ME HANCOCK W SAYEGH MH ADAMS DH
Citation: Mj. Karnovsky et al., CHRONIC REJECTION IN EXPERIMENTAL CARDIAC TRANSPLANTATION IN A RAT MODEL, Clinical transplantation, 8(3), 1994, pp. 308-312

Authors: MANEVAL DC HARRIS MP SUTJIPTO S WEN SF HANCOCK W HUTCHINS BM WILLS KN GREGORY RJ
Citation: Dc. Maneval et al., RECOMBINANT P53 ADENOVIRUS (RAD P53) EFFECTS ON PROLIFERATION OF HUMAN TUMOR-CELL LINES/, Journal of cellular biochemistry, 1994, pp. 115-115

Authors: WILLS KN MANEVAL DC MENZEL P SUTJIPTO S WEN SF NAREDHOOD K HARRIS MP HUANG WM VAILLANCOURT MT HANCOCK W MOULTON M NODELMAN M GREGORY RJ
Citation: Kn. Wills et al., TUMOR-SUPPRESSOR GENE-THERAPY OF CANCER - ADENOVIRAL MEDIATED GENE-TRANSFER OF P53 AND RETINOBLASTOMA CDNA INTO HUMAN TUMOR-CELL LINES, Journal of cellular biochemistry, 1994, pp. 204-204

Authors: GREGORY RJ MANEVAL DC SUTJIPTO S WEN SF HARRIS MP NAREDHOOD K MENZEL P HUANG WM VAILLANCOURT MT HANCOCK W MOULTON M NODELMAN M WILLS KN
Citation: Rj. Gregory et al., TUMOR-SUPPRESSOR GENE-THERAPY OF CANCER - ADENOVIRAL MEDIATED GENE-TRANSFER OF THE P53 CDNA INTO HUMAN TUMOR-CELL LINES, Journal of cellular biochemistry, 1994, pp. 237-237

Authors: VANDERWERF WJ BLAKELY ML HANCOCK W SOARES M LATINNE D BAZIN H BACH FH
Citation: Wj. Vanderwerf et al., SUSTAINED SUPPRESSION OF XENOREACTIVE NATURAL ANTIBODIES - ANTI-IGM MONOCLONAL-ANTIBODY AND ANTI-B CELL IMMUNOSUPPRESSANTS, Transplantation proceedings, 26(3), 1994, pp. 1372-1373

Authors: WATSCHINGER B SAYEGH MH HANCOCK W RUSSELL ME
Citation: B. Watschinger et al., IN-SITU UP-REGULATION OF ENDOTHELIN-1 MESSENGER-RNA AND PEPTIDE EXPRESSION IN ACUTE AND CHRONIC RAT CARDIAC ALLOGRAFT-REJECTION, Circulation, 90(4), 1994, pp. 294-294

Authors: WATSCHINGER B SAYEGH MH HANCOCK W RUSSELL ME
Citation: B. Watschinger et al., IN-SITU UP-REGULATION OF ENDOTHELIN-1 MESSENGER-RNA AND PEPTIDE EXPRESSION IN ACUTE AND CHRONIC RAT CARDIAC ALLOGRAFT-REJECTION, Circulation, 90(4), 1994, pp. 294-294

Authors: MOTTRAM PL HAN WR PURCELL LJ PIETERSZ GA MCKENZIE IFC HANCOCK W
Citation: Pl. Mottram et al., CYTOKINE EXPRESSION AND T-CELL REACTIVITY IN LONG-SURVIVING MOUSE HEART ALLOGRAFTS, Journal of leukocyte biology, 1993, pp. 121-121

Authors: HANCOCK W MOTTRAM PL PURCELL LJ HAN WR PIETERSZ GA MCKENZIE IFC
Citation: W. Hancock et al., PROLONGED SURVIVAL OF MOUSE CARDIAC ALLOGRAFTS AFTER CD4 OR CD8 MONOCLONAL-ANTIBODY THERAPY IS ASSOCIATED WITH SELECTIVE INTRAGRAFT CYTOKINE PROTEIN EXPRESSION - INTERLEUKIN (IL)-4 AND IL-10 BUT NOT IL-2 OR INTERFERON-ALPHA, Transplantation proceedings, 25(5), 1993, pp. 2937-2938
Risultati: 1-20 |